Posters

Evaluation of the iStent inject in pseudophakic eyes with open-angle glaucoma: preliminary results

Poster Details

First Author: V.Vohra UK

Co Author(s):    A. Adam   C. Dineen   B. Karri   I. Madgula           

Abstract Details

Purpose:

To evaluate the efficacy and safety of istent inject implantation in the treatment of progressive open-angle glaucoma (OAG) in pseudophakic eyes.

Setting:

Glaucoma services,Department of Ophthalmology , Royal Preston Hospital, Lancashire Teaching hospital, Preston,United Kingdom

Methods:

A retrospective analysis of records of patients that underwent iStent inject implantation since March 2018 was done for intraocular pressure (IOP) reduction and glaucoma medication load reduction. Safety outcomes included intraoperative and postoperative complications, secondary surgeries and best-corrected visual acuity (BCVA).

Results:

Records of 55 eyes that underwent iStent implantation were analysed with a mean age of  77yrs ( 51- 97 ).The average IOP preoperatively in the analysed eyes was 20.2  ± 6.4 mm Hg. IOP decreased by ≥ 20% compared to  preoperative IOP in 22 eyes completing 3 month and 11 eyes completing 6 months follow up.11 (67%) of the 17 eyes that completed 6 month follow up revealed significant decrease in medication load. Out of 55 eyes evaluated 9 eyes were steroid responder, 3 eyes had malpositioned stents,5 had overimplanted stents and 1 eye had an episode of iris prolapse.

Conclusions:

The early result of iStent inject implant look promising with significant reduction of IOP and medication load in eyes with coexistent primary open angle glaucoma.

Financial Disclosure:

None